SCHEMBL4876397

SCHEMBL4876397

COc1cccc(Cn2c(-c3ccc4nc(-c5sc(C(F)(F)F)nc5C)ccc4c3)c(-c3ccccc3)c3sc(C(=O)O)cc32)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.37
PPARG P37231 3/20 0.36
TP53 P04637 1/20 0.35
THRB P10828 1/20 0.35
MAPK8 P45983 1/20 0.35
HTT P42858 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
USP2 O75604 1/20 0.35
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
PTGES O14684 1/20 0.35
AGTR1 P30556 1/20 0.35
CCR2 P41597 1/20 0.34
GPR55 Q9Y2T6 1/20 0.34
FEN1 P39748 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4878217 0.92 MAPT (0.39) MAPTPPARGTP53THRBMAPK8
SCHEMBL4871848 0.89 CSNK1D (0.39) MAPTPPARGMAPK8PTGESCCR2
SCHEMBL4876393 0.89 ALOX5AP (0.34) MAPTTP53THRBHTTSMN1; SMN2
SCHEMBL4871792 0.87 PPARG (0.41) MAPTPPARGTP53THRBMAPK8
SCHEMBL4867738 0.87 PTGES (0.42) MAPTPPARGTP53THRBMAPK8
SCHEMBL4878878 0.87 LMNA (0.40) MAPTPPARGMAPK8USP2ALDH1A1
SCHEMBL4868814 0.85 EDNRB (0.39) MAPTPPARGTP53THRBMAPK8
SCHEMBL4868490 0.84 PPARG (0.43) MAPTPPARGMAPK8LMNAPTGES
SCHEMBL4868477 0.82 CCR2 (0.41) MAPTPPARGTP53USP2ALDH1A1
SCHEMBL4878213 0.80 KCNH2 (0.37) MAPTTP53THRBCCR2FEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080051384-A1 ANTIVIRAL AGENTS GENELABS TECHNOLOGIES, INC. 2008-02-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080051384-A1 ANTIVIRAL AGENTS EIF2AK2, MAVS, ZC3HAV1 MAPT 4372/4885PPARG 2954/4885TP53 3049/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.